Opportunistic screening for long-term muscle wasting in critically ill patients: insights from an acute pancreatitis cohort.
Humans
Male
Middle Aged
Female
Critical Illness
Pancreatitis
/ diagnostic imaging
Retrospective Studies
Tomography, X-Ray Computed
/ methods
Aged
Intensive Care Units
Adult
Muscular Atrophy
/ diagnostic imaging
Psoas Muscles
/ diagnostic imaging
Acute Disease
Hospitalization
/ statistics & numerical data
Acute pancreatitis
Artificial intelligence
Computed tomography
Critical care
Muscle wasting
Journal
European journal of medical research
ISSN: 2047-783X
Titre abrégé: Eur J Med Res
Pays: England
ID NLM: 9517857
Informations de publication
Date de publication:
22 May 2024
22 May 2024
Historique:
received:
04
03
2024
accepted:
13
05
2024
medline:
23
5
2024
pubmed:
23
5
2024
entrez:
22
5
2024
Statut:
epublish
Résumé
To assess the feasibility of long-term muscle monitoring, we implemented an AI-guided segmentation approach on clinically indicated Computed Tomography (CT) examinations conducted throughout the hospitalization period of patients admitted to the intensive care unit (ICU) with acute pancreatitis (AP). In addition, we aimed to investigate the potential of muscle monitoring for early detection of patients at nutritional risk and those experiencing adverse outcomes. This cohort served as a model for potential integration into clinical practice. Retrospective cohort study including 100 patients suffering from AP that underwent a minimum of three CT scans during hospitalization, totaling 749 assessments. Sequential segmentation of psoas muscle area (PMA) was performed and was relative muscle loss per day for the entire monitoring period, as well as for the interval between each consecutive scan was calculated. Subgroup and outcome analyses were performed including ANOVA. Discriminatory power of muscle decay rates was evaluated using ROC analysis. Monitoring PMA decay revealed significant long-term losses of 48.20% throughout the hospitalization period, with an average daily decline of 0.98%. Loss rates diverged significantly between survival groups, with 1.34% PMA decay per day among non-survivors vs. 0.74% in survivors. Overweight patients exhibited significantly higher total PMA losses (52.53 vs. 42.91%; p = 0.02) and average PMA loss per day (of 1.13 vs. 0.80%; p = 0.039). The first and the maximum decay rate, in average available after 6.16 and 17.03 days after ICU admission, showed convincing discriminatory power for survival in ROC analysis (AUC 0.607 and 0.718). Both thresholds for maximum loss (at 3.23% decay per day) and for the initial loss rate (at 1.98% per day) proved to be significant predictors of mortality. The innovative AI-based PMA segmentation method proved robust and effortless, enabling the first comprehensive assessment of muscle wasting in a large cohort of intensive care pancreatitis patients. Findings revealed significant muscle wasting (48.20% on average), particularly notable in overweight individuals. Higher rates of initial and maximum muscle loss, detectable early, correlated strongly with survival. Integrating this tool into routine clinical practice will enable continuous muscle status tracking and early identification of those at risk for unfavorable outcomes.
Identifiants
pubmed: 38778361
doi: 10.1186/s40001-024-01884-7
pii: 10.1186/s40001-024-01884-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
294Informations de copyright
© 2024. The Author(s).
Références
Bugiantella W, et al. Necrotizing pancreatitis: a review of the interventions. Int J Surg. 2016;28(Suppl 1):S163–71.
doi: 10.1016/j.ijsu.2015.12.038
pubmed: 26708848
Mederos MA, Reber HA, Girgis MD. Acute pancreatitis: a review. JAMA. 2021;325(4):382–90.
doi: 10.1001/jama.2020.20317
pubmed: 33496779
Teresi JA, et al. Guidelines for designing and evaluating feasibility pilot studies. Med Care. 2022;60(1):95–103.
doi: 10.1097/MLR.0000000000001664
pubmed: 34812790
pmcid: 8849521
Werner J, et al. Management of acute pancreatitis: from surgery to interventional intensive care. Gut. 2005;54(3):426–36.
doi: 10.1136/gut.2003.035907
pubmed: 15710995
pmcid: 1774421
Arvanitakis M, et al. ESPEN guideline on clinical nutrition in acute and chronic pancreatitis. Clin Nutr. 2020;39(3):612–31.
doi: 10.1016/j.clnu.2020.01.004
pubmed: 32008871
Le A, et al. Malnutrition imparts worse outcomes in patients admitted for acute pancreatitis. Cureus. 2023;15(3):e35822.
pubmed: 37033570
pmcid: 10075145
Fazzini B, et al. The rate and assessment of muscle wasting during critical illness: a systematic review and meta-analysis. Crit Care. 2023;27(1):2.
doi: 10.1186/s13054-022-04253-0
pubmed: 36597123
pmcid: 9808763
Busireddy KK, et al. Pancreatitis-imaging approach. World J Gastrointest Pathophysiol. 2014;5(3):252–70.
doi: 10.4291/wjgp.v5.i3.252
pubmed: 25133027
pmcid: 4133524
Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(Suppl 1):S31–4.
doi: 10.4103/sja.SJA_543_18
pubmed: 30930717
pmcid: 6398292
Beetz NL, et al. Artificial intelligence-based analysis of body composition in Marfan: skeletal muscle density and psoas muscle index predict aortic enlargement. J Cachexia Sarcopenia Muscle. 2021;12(4):993–9.
doi: 10.1002/jcsm.12731
pubmed: 34137512
pmcid: 8350208
Kim D, et al. Comparative assessment of skeletal muscle mass using computerized tomography and bioelectrical impedance analysis in critically ill patients. Clin Nutr. 2019;38(6):2747–55.
doi: 10.1016/j.clnu.2018.12.002
pubmed: 30612851
Kolck J, et al. Intermittent body composition analysis as monitoring tool for muscle wasting in critically ill COVID-19 patients. Ann Intensive Care. 2023;13(1):61.
doi: 10.1186/s13613-023-01162-5
pubmed: 37421448
pmcid: 10329605
Derstine BA, et al. Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population. Sci Rep. 2018;8(1):11369.
doi: 10.1038/s41598-018-29825-5
pubmed: 30054580
pmcid: 6063941
Robert Koch-Institut (2022): Dashboard zu Gesundheit in Deutschland aktuell—GEDA 2019/2020.
Peterson SJ, Braunschweig CA. Prevalence of sarcopenia and associated outcomes in the clinical setting. Nutr Clin Pract. 2016;31(1):40–8.
doi: 10.1177/0884533615622537
pubmed: 26703961
Mayer KP, et al. Acute skeletal muscle wasting and dysfunction predict physical disability at hospital discharge in patients with critical illness. Crit Care. 2020;24(1):637.
doi: 10.1186/s13054-020-03355-x
pubmed: 33148301
pmcid: 7640401
Tanaka K, Yamada T. Ultrasound measurement of septic shock-induced acute skeletal muscle atrophy in intensive care unit. PM R. 2021;13(4):347–52.
doi: 10.1002/pmrj.12406
pubmed: 32418351
Nakanishi N, et al. Monitoring of muscle mass in critically ill patients: comparison of ultrasound and two bioelectrical impedance analysis devices. J Intensive Care. 2019;7:61.
doi: 10.1186/s40560-019-0416-y
pubmed: 31890223
pmcid: 6916000
Bunnell A, et al. Quantitative neuromuscular ultrasound in intensive care unit-acquired weakness: a systematic review. Muscle Nerve. 2015;52(5):701–8.
doi: 10.1002/mus.24728
pubmed: 26044880
pmcid: 4596754
Krishna SG, et al. Morbid obesity is associated with adverse clinical outcomes in acute pancreatitis: a propensity-matched study. Off J Am Coll Gastroenterol. 2015;110(11):1608–19.
doi: 10.1038/ajg.2015.343
Gullo L, et al. Acute pancreatitis in five European countries: etiology and mortality. Pancreas. 2002;24(3):223–7.
doi: 10.1097/00006676-200204000-00003
pubmed: 11893928
Lambden S, et al. The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care. 2019;23(1):374.
doi: 10.1186/s13054-019-2663-7
pubmed: 31775846
pmcid: 6880479
Inoue S, et al. Post-intensive care syndrome: its pathophysiology, prevention, and future directions. Acute Med Surg. 2019;6(3):233–46.
doi: 10.1002/ams2.415
pubmed: 31304024
pmcid: 6603316
Adrion C, et al. Enhanced recovery after intensive care (ERIC): study protocol for a German stepped wedge cluster randomised controlled trial to evaluate the effectiveness of a critical care telehealth program on process quality and functional outcomes. BMJ Open. 2020;10(9):e036096.
doi: 10.1136/bmjopen-2019-036096
pubmed: 32978185
pmcid: 7520839
Vanhorebeek I, Latronico N, Van den Berghe G. ICU-acquired weakness. Intensive Care Med. 2020;46(4):637–53.
doi: 10.1007/s00134-020-05944-4
pubmed: 32076765
pmcid: 7224132
Hermans G, Van den Berghe G. Clinical review: intensive care unit acquired weakness. Crit Care. 2015;19:274.
doi: 10.1186/s13054-015-0993-7
pubmed: 26242743
pmcid: 4526175
Bruck E, et al. The impact of sepsis, delirium, and psychological distress on self-rated cognitive function in ICU survivors-a prospective cohort study. J Intensive Care. 2018;6:2.
doi: 10.1186/s40560-017-0272-6
pubmed: 29340154
pmcid: 5759266
Friedrich O, et al. The sick and the weak: neuropathies/myopathies in the critically Ill. Physiol Rev. 2015;95(3):1025–109.
doi: 10.1152/physrev.00028.2014
pubmed: 26133937
pmcid: 4491544